Comparison of Cytomegalovirus Loads in Plasma and Leukocytes of Patients with Cytomegalovirus Retinitis

par Jabs, Douglas A., Forman, Michael, Enger, Cheryl, Jackson, J. Brooks
Publié 1999

Characterizing idiopathic pulmonary fibrosis patients using US Medicare-advantage health plan claims data

par Mortimer, Kathleen, Hartmann, Nadine, Chan, Christine, Norman, Heather, Wallace, Laura, Enger, Cheryl
Publié dans BMC Pulm Med (2019)

The treatment patterns, efficacy, and safety of nab(®)-paclitaxel for the treatment of metastatic breast cancer in the United States: results from health insurance claims analysis

par Liang, Caihua, Li, Ling, Fraser, Cindy Duval, Ko, Amy, Corzo, Deyanira, Enger, Cheryl, Patt, Debra
Publié dans BMC Cancer (2015)

Incidence of Foscarnet Resistance and Cidofovir Resistance in Patients Treated for Cytomegalovirus Retinitis

par Jabs, Douglas A., Enger, Cheryl, Forman, Michael, Dunn, J. P., Retinitis, for The Cytomegalovirus, Group, Viral Resistance Study
Publié 1998

Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data

par Mortimer, Kathleen M., Bartels, Dorothee B., Hartmann, Nadine, Capapey, Jorge, Yang, Jing, Gately, Robert, Enger, Cheryl
Publié dans Respiration (2020)

A Survey of Patients’ Perceptions of Pill Appearance and Responses to Changes in Appearance for Four Chronic Disease Medications

par Sarpatwari, Ameet, Gagne, Joshua J., Lu, Zhigang, Campbell, Eric G., Carman, Wendy J., Enger, Cheryl L., Dutcher, Sarah K., Jiang, Wenlei, Kesselheim, Aaron S.
Publié dans J Gen Intern Med (2019)

Identifying and classifying opioid‐related overdoses: A validation study

par Green, Carla A., Perrin, Nancy A., Hazlehurst, Brian, Janoff, Shannon L., DeVeaugh‐Geiss, Angela, Carrell, David S., Grijalva, Carlos G., Liang, Caihua, Enger, Cheryl L., Coplan, Paul M.
Publié dans Pharmacoepidemiol Drug Saf (2019)

Safety study of live, oral human rotavirus vaccine: A cohort study in United States health insurance plans

par Hoffman, Veena, Abu-Elyazeed, Remon, Enger, Cheryl, Esposito, Daina B., Doherty, Michael C., Quinlan, Scott C., Skerry, Kathleen, Holick, Crystal N., Basile, Peter, Friedland, Leonard R., Praet, Nicolas, Wéry, Stéphanie, Willame, Corinne, Dore, David D., Rosillon, Dominique
Publié dans Hum Vaccin Immunother (2018)

Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study

par Hoffman, Veena, Hallas, Jesper, Linder, Marie, Margulis, Andrea V., Suehs, Brandon T., Arana, Alejandro, Phiri, Kelesitse, Enger, Cheryl, Horter, Libby, Odsbu, Ingvild, Olesen, Morten, Perez-Gutthann, Susana, Xu, Yihua, Kristiansen, Nina Sahlertz, Appenteng, Kwame, de Vogel, Stefan, Seeger, John D.
Publié dans Drug Saf (2021)

Measuring problem prescription opioid use among patients receiving long-term opioid analgesic treatment: development and evaluation of an algorithm for use in EHR and claims data

par Carrell, David S., Albertson-Junkans, Ladia, Ramaprasan, Arvind, Scull, Grant, Mackwood, Matt, Johnson, Eric, Cronkite, David J., Baer, Andrew, Hansen, Kris, Green, Carla A., Hazlehurst, Brian L., Janoff, Shannon L., Coplan, Paul M., DeVeaugh-Geiss, Angela, Grijalva, Carlos G., Liang, Caihua, Enger, Cheryl L., Lange, Jane, Shortreed, Susan M., Von Korff, Michael
Publié dans J Drug Assess (2020)